MedPage Today on MSN
CAR7 gene therapy shows promise in T-cell ALL
The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...
Acute lymphoblastic leukemia (ALL) can lead to reduced production of healthy blood cells, increasing the risk of anemia, thrombocytopenia, and infections. Blood clots and central nervous system ...
In a phase 1 study, anti-CD7 chimeric antigen receptor (CAR) T cells induced complete remission in children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia (ALL), with 82% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback